TLC399 (ProDex) in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)

NCT03093701 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

INDUSTRY

Sponsor class

Conditions

Retinal Vein Occlusion
Macula Edema

Interventions

DRUG: TLC399 (ProDex)

Sponsor

Taiwan Liposome Company